Orthopedic M&A Punches Above Its Weight Class
Orthopedic M&A is more active and has higher multiples than general medtech, but economic conditions will limit growth for now....
Orthopedic M&A is more active and has higher multiples than general medtech, but economic conditions will limit growth for now....
Vyrsa manufactures and supports a complete portfolio of FDA-cleared sacroiliac joint fusion devices....
TeDan produces surgical access systems with a specialty focus in spine, neuro, orthopedic and cardiothoracic surgery....
Agili-C is a novel sports medicine technology developed to treat cartilage regeneration in the knee....
Xtant acquired certain assets, including equipment and inventory, used in RTI’s synthetic bone graft business and assumed the lease for...
The merger will integrate Advanced Biologics' proprietary products into Isto's growing portfolio of allografts in their Influx line....
Lima’s solutions include digital innovation and patient-tailored hardware, developed to improve patient outcomes following joint replacement surgery. ...
The acquisition is intended to expand BSC's portfolio to provide more treatment options for chronic low back pain....
Elutia announced the divestiture of the company’s orthobiologics business unit to Berkeley Biologics....
The transaction includes the sale of all cervical and lumbar fusion products, including the STALIF technology platform....
Login
Register for a free account
As a guest member you get access to more articles and webinars every month.